Scinovex
article Open AccessTop 10% cited

Osteocyte control of bone formation via sclerostin, a novel BMP antagonist

The EMBO Journal · 2003 · Vol. 22(23) · pp. 6267–6276
D. G. Winkler
Bone Metabolism and DiseasesBone health and treatmentsTGF-β signaling in diseasesSclerostinOsteocyteBone morphogenetic proteinOsteoblastEndocrinologyInternal medicineBone morphogenetic protein 7BiologyCell biologyBone morphogenetic protein 2

MeSH terms

Alkaline PhosphataseAnimalsBase SequenceBone DevelopmentBone Diseases, MetabolicCell LineCloning, MolecularGenetic MarkersGlycoproteinsHumansKineticsMesodermMice, Inbred C3HMice, TransgenicOsteocytes
Citations
1,106
FWCI
7.06
field-weighted impact
References
82
Percentile
98%
vs. same field & year
Citations per year
Related articles
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

Osteocyte control of bone formation via sclerostin, a novel BMP antagonist · Scinovex